Sexual Health, Metastatic Breast Cancer, Dana-Farber Study
Summary
A clinical trial sponsored by Dana-Farber Cancer Institute has been registered on ClinicalTrials.gov (NCT07519200). The study examines sexual health interventions in patients with metastatic breast cancer.
What changed
A new clinical trial (NCT07519200) titled 'Sexual Health, Metastatic Breast Cancer' sponsored by Dana-Farber Cancer Institute has been registered on ClinicalTrials.gov. The study focuses on sexual health interventions for patients with metastatic breast cancer.
Healthcare providers and patients interested in clinical trial enrollment opportunities may review the study details and eligibility criteria on ClinicalTrials.gov.
What to do next
- Monitor for trial updates
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NLM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.